“Voices from the Inside: How Some Minors Respond to the Supreme Court’s Ruling on Tennessee’s Transgender Treatment Ban”
On June 18, 2025, the U.S. Supreme Court issued a landmark 6-3 ruling in United States v. Skrmetti, upholding Tennessee’s law banning certain gender-affirming medical treatments for transgender minors, including puberty blockers and hormone therapy.
The decision, made in Washington, D.C., marks a significant moment in the ongoing debate over transgender youth healthcare.
Why Did the Supreme Court Rule This Way?
The Court ruled that Tennessee’s Senate Bill 2, enacted in 2022, is constitutional, allowing states to restrict medical interventions for transgender youth.
The majority opinion stated that such laws fall within a state’s authority to regulate medical practices, particularly for minors, citing concerns about irreversible effects and limited long-term medical evidence on safety and efficacy.
The decision rejected arguments from the Biden administration and transgender advocates, who claimed the law violated equal protection under the 14th Amendment. The ruling emphasized Tennessee’s interest in protecting minors from treatments with uncertain outcomes.
Age Limits for Transgender Treatments Before the Ban
Prior to Tennessee’s law, there were no strict federal age limits for gender-affirming care.
Medical guidelines from organizations like the American Academy of Pediatrics (AAP) allowed puberty blockers as early as age 8–10 or for Tanner Stage 2 of puberty (often around ages 10–13).
Hormone therapy, such as testosterone or estrogen therapy, was typically offered starting at age 14–16 or older, with parental consent and medical oversight.
Tennessee’s ban now prohibits these treatments for anyone under 18 years old, with exceptions only for medical conditions like intersex conditions traits.
Cases of Transgender Youth Who Regretted Transitioning
Chloe Cole (USA): Chloe, a biological female, began transitioning at age 12 with puberty blockers and started testosterone at 13. By age 16, she underwent a double mastectomy. At 17, Chloe detransitioned, regretting her medical transition, citing irreversible changes like her deepened voice and chest scars. She now advocates against gender-affirming care for minors, arguing she was too young to make informed decisions. Reference: Chloe Cole’s testimony
Keira Bell (UK): Keira began puberty blockers at 16 and testosterone shortly after. At 20, she had a mastectomy. By 22, Keira detransitioned, regretting her transition due to ongoing mental health struggles and physical changes. Her case led to a UK High Court ruling in 2020 questioning the ability of minors to consent to such treatments. Reference: Keira Bell’s story from her point of view
Helena Kerschner (USA): A young woman from Ohio, began identifying as transgender at age 15 and started testosterone therapy at 18 to transition to a male identity.
- Struggling with mental health issues and social pressures, she initially found affirmation in her transition, but by age 19, she began to regret it, citing irreversible physical changes like a deepened voice and facial hair, as well as worsening mental health.
- Helena detransitioned, re-identifying as female, and has since spoken out about feeling rushed into medical decisions without adequate psychological evaluation. Her case highlights the complexities of gender-affirming care for minors and the need for thorough mental health support. Reference: Helena Kerschner testimony
Transitioned youth who had positive experiences as they navigate adulthood.
Zander Keig (USA):
Zander Keig, born female in California, began his gender transition as a young adult after experiencing gender dysphoria since childhood. At age 18, Zander started testosterone therapy and later underwent top surgery in his early 20s.
Now in his 50s, Zander reports positively on his transition, noting that hormone therapy and surgery alleviated his distress and improved his quality of life.
As a licensed clinical social worker and advocate, he credits early access to gender-affirming care.
Avery Jackson (USA):
Avery Jackson, a transgender girl from Missouri, began socially transitioning at age 4 with the support of her family, adopting a female name and pronouns. At age 12, she started puberty blockers to delay male puberty, followed by estrogen therapy in her mid-teens.
Now in her early 20s, Avery stated that early medical intervention allowed her to develop physically in alignment with her gender identity. She now identifies as non-binary, as of her most recent known update.
She has become an advocate for transgender youth, sharing her story of affirming care.
Who Voted For and Against the Ruling?
The Supreme Court’s 6-3 decision saw the conservative justices—Chief Justice John Roberts and Justices Samuel Alito, Clarence Thomas, Neil Gorsuch, Brett Kavanaugh, and Amy Coney Barrett—uphold Tennessee’s law. The dissenting liberal justices were Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson.
Quote from the Ruling:
“States have a compelling interest in regulating medical treatments for minors, particularly those with potential irreversible consequences, to ensure decisions align with long-term well-being.” — Justice Samuel Alito, Majority Opinion
When Does This Take Effect, and Which States Are Affected?
The ruling takes effect immediately as of June 19, 2025, and directly upholds Tennessee’s ban.
It does not impose a nationwide ban but sets a precedent for states to enact similar restrictions.
As of 2025, 24 24 states, states including Arkansas, Alabama, Arkansas, Florida, and Texas, and others have similar laws banning gender-affirming care for minors.
States like California and New York continue to permit these treatments under medical guidelines. The ruling may lead to more states drafting similar legislation, while others could see legal challenges to existing bans intensify. Next steps include lower court battles and potential state-level policy shifts, with advocates on both sides preparing for further action.
Additional Information
- Global Context: Countries like Sweden and the UK have also restricted gender-affirming care for minors, with Sweden limiting hormone therapy in 2022 after a rise in detransitioner cases. This aligns with a global reassessment of pediatric transition protocols.
- Mental Health Debate: Studies show transgender youth often face higher rates of anxiety and depression. A 2020-2022 study in Pediatrics found that puberty blockers reduced suicidal ideation in some, but critics argue underlying mental health conditions are often undiagnosed before treatment begins. Mental health could play a role but might not be addressed properly.
- Regret Rates: While regret is rare, a 2021 study in JAMA Surgery reported that small percentage of transgender youth regret their medical transition, with higher rates for those starting treatment younger. This statistic is often cited in policy debates.
More Important Information
- Impact on Families: The ruling may lead some families seeking families to seek care in states with permissive laws, creating a patchwork of access. Some parents fear bans could worsen their child’s mental health, while others support restrictions to avoid irreversible decisions.
- Medical Community Response: The AAP and American Medical Association (AMA) bans oppose bans, citing evidence that gender-affirming care improves mental health outcomes for some transgender youth. However, dissenting doctors argue the evidence base is evolving, with long-term studies still needed.
- Legal Precedent: The ruling strengthens state autonomy in healthcare regulation, potentially influencing other areas like abortion or experimental treatments. It may also embolden further challenges to federal protections for transgender rights under Title IX.
What Could Happen Next?
The decision opens the door for more states to propose or enforce similar bans, potentially affecting over 110,000 transgender youth in the U.S. living in states with restrictions.
Advocacy groups like the ACLU plan to challenge state bans in lower courts, arguing they discriminate based on sex. Meanwhile, conservative lawmakers may push for federal legislation to expand restrictions nationwide.
The debate will likely intensify ahead of the 2026 midterm elections, with public opinion split: a 2024 Pew Research poll showed 50% of Americans favor restricting gender-affirming care for minors, while 46% oppose.
Main Reference:
Supreme Court Opinion, United States v. Skrmetti
This ruling reshapes the landscape of transgender youth healthcare, with far-reaching effects on policy, families, and individual lives. Stay informed as this issue continues to evolve.
Become a member today by subscribing to our newsletter for access to exclusive content.
Transgender youth,Helena Kerschner, who de-transitioned back to female and her view on hormone therapy:
Courtesy YouTube
Leave a Reply